RNR Posts Q3 Results as Put Hedges Unwind and Peers Outperform

RenaissanceRe Holdings reported third-quarter results on October 28 with the stock already down 3.7% on the week, a sharper slide than almost any name in its peer group.

Short interest at RNR is modest but has been creeping higher. The short position amounts to roughly 3% of the free float, about 1.36 million shares, up 3.2% from a week ago, though still 6.9% below where it stood a month ago. The trend this week reversed a month-long decline, suggesting some fresh positioning ahead of the print rather than a sustained bearish build. Borrowing costs remain negligible at 0.40%, and the borrow market is extremely loose: availability is running at over 2,200% of short interest, meaning there are more than twenty shares available to lend for every one already out on loan. That rules out any squeeze dynamic. Options positioning is the more interesting signal. The put/call ratio is 4.34, well above its 20-day average of 2.71. The ratio sat below 1.3 as recently as October 15, then surged to a 52-week peak of 5.99 on October 19 before pulling back to current levels. That pattern reflects a concentrated hedge build in the run-up to earnings rather than a lasting structural shift.

The Street is broadly cautious but not bearish. The consensus mean price target is $349, just 2.3% above Tuesday's close of $341.22, leaving almost no implied return on a neutral-weighted book. Wells Fargo and JP Morgan both trimmed targets in mid-October, moving to $319 and $355 respectively, while maintaining neutral-equivalent ratings. TD Cowen nudged its target up slightly to $320. The range of targets from recent coverage, $319 to $365, brackets the current price with limited conviction on either side. Factor scores offer some support: the earnings yield ranks in the 90th percentile of the universe, and EV/EBIT sits in the 85th percentile, pointing to valuation that looks cheap on an income basis. EPS surprise history also ranks well, in the 79th percentile. Against that, the 12-month forward EPS growth score ranks in just the 8th percentile, reflecting the bear case concern that property reinsurance premiums fell 24% in the first half of 2026 versus 2025 and that further pricing pressure is coming. The Casualty and Specialty segment continues to run at an underwriting loss.

On price, RNR has underperformed its closest peers by a significant margin this week. EG fell just 0.5% on the week and ACGL dropped 0.9%, while CB was nearly flat, down 0.4%. ORI came closest to matching RNR's weakness at down 4%, though CINF bucked the group entirely, gaining 5.4%. RNR's 3.7% weekly decline therefore looks stock-specific. The stock has recovered 4.8% over the past month, so the week's selloff arrived against a backdrop of recent relative strength rather than a deteriorating trend.

The only meaningfully different signal from ownership comes from the activist register. Orbis Investment Management reduced its stake from 5.5% to 3.6% as of May 2025, dropping below the 5% reporting threshold. T. Rowe Price similarly trimmed from 6.1% to 4.1% as of February 2026. Both moves are as-last-disclosed and reflect the standard caveat that holders falling below 5% may not file again. On the insider side, all recent trades are net sales. The Chief Portfolio Officer sold just over $6.6 million of stock across August and September under a pre-arranged 10b5-1 plan, a scheduled disposal rather than a discretionary signal. The CFO sold roughly $1.7 million in late July outside any such plan, which carries somewhat more weight, though the amounts are not unusual relative to the company's market cap of $14.2 billion.

The most recent comparable earnings print, the Q2 release in late July, produced a 3.6% gain the following day before fading to a 0.8% net gain over the subsequent five sessions. Whether the Q3 print generates a similar relief trade or confirms the defensive options positioning was well-placed is now the data point to track.